cadriovascular risk of ESRD patients who on regular hemodialysis by using augmentation index Augmentation index, Central blood pressure, Cool dialysate hemodialysis, Lowering temperature, End stage renal disease, Cardiovascular disease
Conditions
Interventions
Group I: patients were first treated with cool dialysate (35.5 c) for first week. After that, patients received normal dialysate (37.0 c) in another week.
Group II: patients were first treated with n
Experimental Other,No Intervention Other
Cool dialysate hemodialysis,normal temperature dialysate hemodialysis
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) were an adult patient (>18 years) and provided an informed written consent; (2) had ESRD treated with regular hemodialysis two or three times a week for >3 months at KCMH; and (3) had no history of IDH during 1 month before enrollment.
Exclusion criteria
Exclusion criteria: (1) chronic atrial fibrillation or other arrhythmia; (2) history of coronary artery diseases and have not been treated or have been treated less than 3 months before participating in the study; (3) history of cerebrovascular event less than 3 months; (4) structural heart disease; (5) abnormal electrolyte; (6) patients who did not consent or change their minds after participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the intradialytic AIx between cool (35.5 0C) and normal (37.00C) dialysate HD in End Stage Kidney Disease 2 weeks Augmentation index | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the central BP changes, peripheral BP change, hs Troponin-I and observe adverse effect between cool (35.5 0C) and normal (37.00C) dialysate HD in End Stage Kidney Disease. 2 weeks central blood pressure, peripheral blood pressure, hs Tn-I, adverse effect | — |
Countries
Thailand
Contacts
Public ContactKanokwan Khositphanitkul
Falculty of Medicine, Chulalongkorn University,
Outcome results
None listed